San Francisco's bullpen just lost one of its few sure things. The Giants placed reliever Keaton Winn on the 15-day injured list with right elbow neuritis, and given how his last elbow issue played out, nobody in the Bay Area is treating this one lightly.
The move stings because Winn has quietly been one of the most reliable arms Bob Melvin has had at his disposal in 2026. Across 44 appearances he carried a 3.35 ERA and led the Giants with 14 holds, more than double-digits ahead of every other reliever on the roster, all while working in a bullpen that's ranked among the worst in the sport this year.
This isn't Winn's first trip to the IL this season, and it isn't his first fight with this exact elbow either. He already missed time earlier in 2026 with an elbow strain dating back to June 11. Go back further and the pattern gets scarier: in July 2024, Winn underwent ulnar nerve transposition surgery that ended his season, a procedure directly tied to nerve irritation around that same elbow.
That surgery is exactly why 'neuritis' is the word that should worry Giants fans. Neuritis means inflammation of a nerve, and this is the same joint where Winn already had a nerve relocated two years ago. San Francisco converted him to a full-time reliever coming out of that recovery, a move that had clearly paid off before this latest setback.
The corresponding move was simple roster math, recalling lefty Reiver Sanmartin to fill the spot, but replacing Winn's production isn't nearly as easy. San Francisco is squarely in the fantasy-relevant, standings-relevant stretch of August, and losing a trusted setup arm to an elbow issue with recurring history is the kind of thing that can quietly wreck a bullpen down the stretch.
For now there's no word on a shutdown or surgery, just a 15-day IL stint and hope that rest handles it. But with Winn's elbow file already including one operation, the Giants and their fans will be watching every update out of the training room a lot more closely than a typical neuritis diagnosis would usually warrant.